Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation

Abstract

Abundance and activity of p53 are predominantly regulated posttranslationally. Structural disturbance in transcribed genes induced by radiation, e.g. DNA damage, or by transcriptional inhibitors cause p53 protein stabilization by a yet unknown mechanism. Using stable and transient transfections for the analysis of p53 mutant proteins, we have ruled out a role in stabilization by UV, gamma irradiation or actinomycin C for the following putative phosphorylation sites in the p53 protein: serines 6, 9, 15, 33, 315 and 392, and threonine 18. By double mutation combinations of phosphorylations were also ruled out; 6,9; 15,18; 15,37. These mutations eliminate modifications by casein kinases I and II, DNA-PK, ATM, CDK and JNK. Also the 30 carboxyterminal amino acids are not required for induced p53 stabilization. Thus neither phosphorylations of individual amino acids nor interactions of the carboxyterminus of p53 with cellular macromolecules appear to play a role in the stabilization process. The only single prerequisite for induced stabilization of p53 is its prior destabilization by Mdm2. However, the level of active Mdm2 must be controlled carefully: overexpression of Mdm2 inhibits UV induced p53 stabilization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Barak Y, Gottlieb E, Juven-Gershon T and Oren M. . 1994 Genes Dev. 8: 1739–1749.

  • Baudier J, Delphin C, Grunwald D, Khochbin S and Lawrence JJ. . 1992 Proc. Natl. Acad. Sci. USA 89: 11627–11631.

  • Bayle JH, Elenbaas B and Levine AJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 5729–5733.

  • Bender K, Blattner C, Knebel A, Iordanov M, Herrlich P and Rahmsdorf HJ. . 1997 J. Photochem. Photobiol. B 37: 1–17.

  • Bischoff JR, Friedman PN, Marshak DR, Prives C and Beach D. . 1990 Proc. Natl. Acad. Sci. USA 87: 4766–4770.

  • Blattner C, Knebel A, Radler-Pohl A, Sachsenmaier C, Herrlich P and Rahmsdorf HJ. . 1994 Environ. Mol. Mutagen. 24: 3–10.

  • Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA and Jackson SP. . 1995 Cell 80: 813–823.

  • Böttger A, Böttger V, Sparks A, Liu WL, Howard SF and Lane DP. . 1997 Curr. Biol. 7: 860–869.

  • Candeias SM, Durum SK and Muegge K. . 1997 Biochimie 79: 607–612.

  • Chen C and Okayama H. . 1987 Mol. Cell. Biol. 7: 2745–2752.

  • Chen L, Agrawal S, Zhou W, Zhang R and Chen J. . 1998 Proc. Natl. Acad. Sci. USA 95: 195–200.

  • Cohen PA, Mani J-C and Lane DP. . 1998 Oncogene, in press.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Dutta A, Ruppert JM, Aster JC and Winchester E. . 1993 Nature 365: 79–82.

  • Fontoura BM, Sorokina EA, David E and Carroll RB. . 1992 Mol. Cel. Biol. 12: 5145–5151.

  • Foord OS, Bhattacharya P, Reich Z and Rotter V. . 1991 Nucleic Acids Res. 19: 5191–5198.

  • Fried LM, Koumenis C, Peterson SR, Green SL, van Zijl P, Allaunis-Turner J, Chen DJ, Fishel R, Giaccia AJ, Brown JM and Kirchgessner CU. . 1996 Proc. Natl. Acad. Sci. USA 93: 13825–13830.

  • Fritsche M, Haessler C and Brandner G. . 1993 Oncogene 8: 307–318.

  • Gottlieb TM and Oren M. . 1996 Biochim. Biophys. Acta 1287: 77–102.

  • Gurley KE and Kemp CJ. . 1996 Carcinogenesis 17: 2537–2542.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Herrmann CP, Kraiss S and Montenarh M. . 1991 Oncogene 6: 877–884.

  • Hoeijmakers JHJ, Egly J-M and Vermeulen W. . 1996 Curr. Opin. Genet. Dev. 6: 26–33.

  • Honda R, Tanaka H and Yasuda H. . 1997 FEBS Lett. 420: 25–27.

  • Huang LC, Clarkin KC and Wahl GM. . 1996 Cancer Res. 56: 2940–2944.

  • Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886.

  • Hupp TR and Lane DP. . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 195–206.

  • Hupp TR and Lane DP. . 1995 J. Biol. Chem. 270: 18165–18174.

  • Ishioka C, Englert C, Winge P, Yan YX, Engelstein M and Friend SH. . 1995 Oncogene 10: 1485–1492.

  • Jayaraman J and Prives C. . 1995 Cell 81: 1021–1029.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304–6311.

  • Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF and Meek DW. . 1997 Oncogene 15: 1727–1736.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C and Pan ZQ. . 1997 Mol. Cell. Biol. 17: 7220–7229.

  • Kubbutat MH, Jones SN and Vousden KH. . 1997 Nature 387: 299–303.

  • Kulesz-Martin MF, Lisafeld B, Huang H, Kisiel ND and Lee L. . 1994 Mol. Cell. Biol. 14: 1698–1708.

  • Lee S, Elenbaas B, Levine A and Griffith J. . 1995 Cell 81: 1013–1020.

  • Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049.

  • Lin J, Chen J, Elenbaas B and Levine AJ. . 1994 Genes Dev. 8: 1235–1246.

  • Lu X and Lane DP. . 1993 Cell 75: 765–778.

  • Lu H, Fisher RP, Bailey P and Levine AJ. . 1997 Mol, Cell, Biol. 17: 5923–5934.

  • Maki CG, Huibregtse JM and Howley PM. . 1996 Cancer Res. 56: 2649–2654.

  • Maki CG and Howley PM. . 1997 Mol. Cell. Biol. 17: 355–363.

  • Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694.

  • Marston NJ, Jenkins JR and Vousden KH. . 1995 Oncogene 10: 1709–1715.

  • Meek DW, Simon S, Kikkawa U and Eckhart W. . 1990 Embo J. 9: 3253–3260.

  • Meek DW. . 1994 Semin. Cancer Biol. 5: 203–210.

  • Midgley CA and Lane DP. . 1997 Oncogene 15: 1179–1189.

  • Miller AD and Rosman GJ. . 1989 BioTechniques 7: 980–990.

  • Milne DM, Palmer RH and Meek DW. . 1992 Nucleic Acids Res. 20: 5565–5570.

  • Milne DM, Campbell DG, Caudwell FB and Meek DW. . 1994 J. Biol. Chem. 269: 9253–9260.

  • Milne DM, McKendrick L, Jardine LJ, Deacon E, Lord JM and Meek DW. . 1996 Oncogene 13: 205–211.

  • Molinari M, Okorokov AL and Milner J. . 1996 Oncogene 13: 2077–2086.

  • Moll UM, LaQuaglia M, Benard J and Riou G. . 1995 Proc. Natl. Acad. Sci. USA 92: 4407–4411.

  • Morgenstern JP and Land H. . 1990 Nucleic Acids Res. 18: 3587–3596.

  • Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F and Deppert W. . 1995 EMBO J. 14: 4442–4449.

  • Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T. . 1996 Genes Dev. 10: 2055–2066.

  • Okorokov AL, Ponchel F and Milner J. . 1997 EMBO J. 16: 6008–6017.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Rahmsdorf HJ, Schönthal A, Angel P, Litfin M, Rüther U and Herrlich P. . 1987 Nucleis Acids Res. 15: 1643–1659.

  • Renzing J and Lane DP. . 1995 Oncogene 10: 1865–1868.

  • Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E and Xie D. . 1997 Biochem. 36: 10117–19124.

  • Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. . 1993 Cell 75: 495–505.

  • Shaulsky G, Goldfinger N, Ben-Ze'ev A and Rotter V. . 1990 Mol. Cell. Biol. 10: 6565–6577.

  • Shieh SY, Ikeda M, Taya Y and Prives C. . 1997 Cell 91: 325–334.

  • Stürzbecher HW, Brain R, Addison C, Rudge K, Remm M, Grimaldi M, Keenan E and Jenkins JR. . 1992 Oncogene 7: 1513–1523.

  • Svejstrup JQ, Vichi P and Egly J-M. . 1996 TIBS 21: 346–350.

  • Takenaka I, Morin F, Seizinger BR and Kley N. . 1995 J. Biol. Chem. 270: 5405–5411.

  • Wagner P, Fuchs A, Gotz C, Nastainczyk W and Montenarh M. . 1998 Oncogene 16: 105–111.

  • Wang XW, Forrester K, Yeh H, Freitelson MA, Gu JR and Harris CC. . 1994 Proc. Natl. Acad. Sci. USA 91: 2230–2234.

  • Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC. . 1995 Nat. Genet. 10: 188–195.

  • Wu Y, Liu Y, Lee L, Miner Z and Kulesz-Martin M. . 1994 EMBO J. 13: 4823–4830.

  • Xiao H, Pearson A, Coulombe B, Truant R, Zhang S, Regioer JL, Triezenberg SJ, Reinberg D, Flores O, Ingles CJ and Greenblatt J. . 1994 Mol. Cell. Biol. 14: 7013–7024.

  • Yamaizumi M and Sugano T. . 1994 Oncogene 9: 2775–2784.

  • Youmell M, Park SJ, Basu S and Price BD. . 1998 Biochem. Biophys. Res. Commun. 245: 514–518.

  • Zakut-Houri R, Bienz-Tadmor B, Givol D and Oren M. . 1985 EMBO J. 4: 1251–1255.

  • Zhang Y, Xiong Y and Yarborough WG. . 1998 Cell 92: 725–734.

Download references

Acknowledgements

We would like to thank Michael Fritsche, Freiburg, for plasmids and cells, and Hans Weiher and Norma Howells, Karlsruhe, for help with the cultivation of primary murine fibroblasts. HJR was supported by the Mildred-Scheel-Stiftung (W 86/94) and the Deutsche Forschungsgemeinschaft (Ra 247/6-1) and PH by Fonds der Chemischen Industrie.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blattner, C., Tobiasch, E., Litfen, M. et al. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene 18, 1723–1732 (1999). https://doi.org/10.1038/sj.onc.1202480

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202480

Keywords

This article is cited by

Search

Quick links